Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
86
CIMA_AEMPS:67
NMPA:16
PHILIPPINES:2
+1 more agencies
Drug Approvals
Atomoxetine Hydrochloride Oral Solution
- Product Name
- 盐酸托莫西汀口服溶液
- Approval Number
- 国药准字HJ20180057
- Approval Date
- Oct 17, 2023
NMPA
Atomoxetine Hydrochloride Capsules
- Product Name
- 择思达
- Approval Number
- 国药准字HJ20160112
- Approval Date
- Aug 13, 2020
NMPA
Atomoxetine Hydrochloride Capsules
- Product Name
- 择思达
- Approval Number
- 国药准字HJ20160121
- Approval Date
- Aug 13, 2020
NMPA
Atomoxetine Hydrochloride Capsules
- Product Name
- 择思达
- Approval Number
- 国药准字HJ20160119
- Approval Date
- Aug 13, 2020
NMPA
Atomoxetine Hydrochloride Capsules
- Product Name
- 择思达
- Approval Number
- 国药准字HJ20160117
- Approval Date
- Aug 13, 2020
NMPA
Atomoxetine Hydrochloride Capsules
- Product Name
- 择思达
- Approval Number
- 国药准字HJ20160116
- Approval Date
- Aug 13, 2020
NMPA
Atomoxetine Hydrochloride Capsules
- Product Name
- 择思达
- Approval Number
- 国药准字HJ20160123
- Approval Date
- Aug 13, 2020
NMPA
Atomoxetine Hydrochloride Capsules
- Product Name
- 择思达
- Approval Number
- 国药准字HJ20160118
- Approval Date
- Aug 13, 2020
NMPA
Atomoxetine Hydrochloride Capsules
- Product Name
- 择思达
- Approval Number
- 国药准字HJ20160120
- Approval Date
- Aug 13, 2020
NMPA
Atomoxetine Hydrochloride Capsules
- Product Name
- 择思达
- Approval Number
- 国药准字HJ20160114
- Approval Date
- Aug 13, 2020
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found